August 13, 2026

NeuroOne Reports Fiscal Q3 2026 Results: Revenue Up 16%, Backlog Grows, and Drug Delivery Platform Nears Launch

August 3, 2026

NeuroOne to Announce Fiscal Q3 2026 Results and Corporate Update

July 30, 2026

NeuroOne Releases White Paper on StereoCED™ Platform for CNS Drug Delivery Ahead of Fiscal Year-End Availability

July 28, 2026

NeuroOne Reports Real-World Evidence of Seizure Reduction with OneRF Ablation System

July 16, 2026

NeuroOne Technology to Be Used in Mayo Clinic Pediatric Brain Cancer Study